OPDIVO 10 mg/mL concentrate for solution for infusion., JNJ-63723283, Zr89
10353
Phase 2 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion., JNJ-63723283, Zr89 for Patients with metastatic solid tumours, where clinical data has shown a rationale for ICI therapy. is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Patients with metastatic solid tumours, where clinical data has shown a rationale for ICI therapy.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active